Merck & Co., Inc. (MRK) Highlights Progress On Its Strategic Initiative To Sharpen Commercial And R&D Focus; Drive Growth And Productivity  
5/6/2014 10:23:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today is hosting an Investor Briefing at the company’s research facility in Boston. The briefing is also available via webcast at starting at 9:00 a.m. EDT.

Help employers find you! Check out all the jobs and post your resume.